The phase 3 HYPERION trial of Winrevair in adults with newly diagnosed pulmonary arterial hypertension functional class two ...

Gossamer Bio Inc. has released new data showing its inhaled kinase inhibitor, seralutinib, has long-lasting effects on ...

The HYPERION study will be stopped early due to positive efficacy data from across the sotatercept clinical program.

Lung transplant recipients are highly susceptible to infection, the researchers noted, and P. aeruginosa is a leading cause of bacterial pneumonia for them. Indeed, it was the most frequently isolated ...

A new FTC report found that pharmacy benefit managers have inflated the price of life-saving generic prescription drugs, ...

Medicare Advantage patients treated in value-based care models saw better outcomes than those treated in fee-for-service ...

Tectonic Therapeutic said the findings support the design and population for Phase 2 APEX trial, which will test TX45 in ...

Chronic thromboembolic pulmonary hypertension occurs in a proportion ... with 2 of 10 in the CTEPD group identified as having a coupling ratio of <0.68, suggesting occult RV dysfunction, while 3 of 10 ...

Aspen Dental® is pleased to announce that Dr. Mindy J. Streem has joined Aspen Dental Management Inc. as its new Director of Orthodontic Support. Dr. Streem, a highly respected leader in the ...

Chicago Partners Investment Group LLC increased its position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 6.3% ...

Kaiser Foundation Health Plan, Inc., Kaiser Foundation Hospitals, Risant Health, Inc., and their respective subsidiaries and affiliates (KFHP/H & Risant Health) reported consolidated 2024 annual ...

GPS Wealth Strategies Group LLC lowered its position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 27.7% in the ...